(Q58535949)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

0 references

0 references

0 references

biomedical engineering

0 references

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Gennaro Ciliberto

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Maione D

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Scoumanne A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Costa P

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Hansen MB

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Svenson M

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Bendtzen K

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Alonzi T

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Paonessa G

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Cortese R

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Savino R

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 October 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

997-1001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nbt1097-997

6 November 2019

exact match

0 references

cites work

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

Biological and clinical aspects of interleukin 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phosphatase (SEAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

Impaired immune and acute-phase responses in interleukin-6-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

Stimulation of the B9 hybridoma cell line by soluble interleukin-6 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

High-affinity IgG autoantibodies to IL-6 in sera of normal individuals are competitive inhibitors of IL-6 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

Cytokine antagonists and their potential therapeutic use

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

7 January 2021

https://api.crossref.org/works/10.1038%2FNBT1097-997

1 reference

7 January 2021

Specific human granulocyte-macrophage colony-stimulating factor antagonists.

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

7 January 2021

Interleukin 6 is essential for in vivo development of B lineage neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

7 January 2021

Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

7 January 2021

Anti-interleukin-6 antibodies in normal human serum

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

7 January 2021

Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

7 January 2021

The development of anti-interleukin-2 antibodies in patients treated with recombinant human interleukin-2 (IL-2)

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

7 January 2021

IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage.

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

7 January 2021

Tolerance is overcome in beef insulin-transgenic mice by activation of low-affinity autoreactive T cells

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

7 January 2021

Saturation mutagenesis of the human interleukin 6 receptor-binding site: implications for its three-dimensional structure

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

7 January 2021

Induction of autoreactive B cells allows priming of autoreactive T cells

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

7 January 2021

Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

7 January 2021

Single-step purification and structural characterization of human interleukin-6 produced in Escherichia coli from a T7 RNA polymerase expression vector.

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

7 January 2021

Binding of cytokines to pharmaceutically prepared human immunoglobulin

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

7 January 2021

Influence of interleukin-6 (IL-6) autoantibodies on IL-6 binding to cellular receptors

1 reference

https://api.crossref.org/works/10.1038%2FNBT1097-997

7 January 2021

Identifiers

DOI

10.1038/NBT1097-997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9335053%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference